Expressivity (genetics)

Last updated

In genetics, expressivity is the degree to which a phenotype is expressed by individuals having a particular genotype. Alternatively, it may refer to the expression of a particular gene by individuals having a certain phenotype. Expressivity is related to the intensity of a given phenotype; it differs from penetrance, which refers to the proportion of individuals with a particular genotype that share the same phenotype. [1]

Contents

Variable expressivity

Variable expressivity refers to the phenomenon by which individuals with a shared genotype exhibit varying phenotypes. [2] This can be further described as a spectrum of associated traits that can range in size, colour, intensity, and so forth. Variable expressivity can be seen in plants and animals, such as differences in hair colour, leaf size, and severity of diseases.

Mechanisms influencing expressivity

Figure 1. This figure illustrates some factors influencing gene expressivity including cis-regulatory elements, trans-acting factors, environmental factors, and DNA modification. Credited with Biorender.com. Factors Regulating Gene Expressivity.png
Figure 1. This figure illustrates some factors influencing gene expressivity including cis-regulatory elements, trans-acting factors, environmental factors, and DNA modification. Credited with Biorender.com.

This variation in expression can be affected by modifier genes, epigenetic factors or the environment. [3]

  1. Modifier genes can alter the expression of other genes in either an additive or multiplicative way. [3] Meaning the phenotype that is observed can be a result of two different alleles (gene variants) being summed or multiplied. However, a reduction in expression may also occur in which the primary locus, where the gene is located, is affected. [4]
  2. Epigenetic factors are heritable changes in the chromatin accessibility that affect the gene expression. [5] Epigenetic factors can include:
    1. Cis-regulatory elements, which are regions of non-coding DNA that regulate transcription of genes, such as promoters or enhancers. [6]
    2. Trans-regulatory elements, which are regulatory proteins, such as transcription factors (TFs) that bind to DNA to regulate gene expression. [7]
    3. Histone modifications, which regulate the accessibility of chromatin for gene transcription. [8]
    4. Chromatin variants, which are different states of chromatin. [9]
    5. Genomic imprinting, which determines whether some genes inherited from the mother and father get expressed. [10]
  3. The expressivity of a gene can be influenced by the environmental conditions. [11] For example, pigmentation in the fur of Himalayan rabbits is determined by the C gene, the activity of which is dependent on temperature. [12] During rearing of genetically identical rabbits, if a rabbit’s fur reaches a temperature higher than 35 oC, the fur will develop as white. If a rabbit’s fur stays at a temperature between 15 and 25 oC, the fur will develop as black.

Variable expressivity in plants and animals

Plants

Expressivity is commonly seen in plants and can be regulated by complex interactions between the environment, hormonal signalling, and genetics. An example of expressivity in plants caused by a rare gene is the variation in the number of branches. Initially identified in sorghum plants, this rare gene is called the Sorghum bicolorAxillary Branched Mutant (SbABM). [13] Over several years of studies on SbABM in the rabisorghum plant, researchers found that the progeny of the plants ranged from having 0 to 33 branches, even though they all had the same SbABM genotype. [13]

Animals

A well-known example is polydactyly in Hemingway’s cats, which is the presence of extra toes. The number of extra toes can differ between cats, due to variable expressivity of the ZRS gene in the feline chromosome A2. ZRS enhances the activity of the SHH gene, which is involved in limb development, and this has been shown to cause extra toes. Although polydactyly is caused by an autosomal dominant allele, the variable expressivity (number of toes) of polydactyly in cats may be influenced by the tissues surrounding the region that would develop into toes. [14]

Clinical application

Figure 3. Example of Cleft lip seen as a result of the Van der Woude syndrome. Incomplete Cleft Lip.png
Figure 3. Example of Cleft lip seen as a result of the Van der Woude syndrome.
Figure 2. Individuals with Marfan Syndrome usually have fingers that are longer than those that do not have the syndrome. The extremity of difference in finger length is a result of variable expressivity. Marfan thumb sign.png
Figure 2. Individuals with Marfan Syndrome usually have fingers that are longer than those that do not have the syndrome. The extremity of difference in finger length is a result of variable expressivity.

Some common syndromes that involved phenotypic variability due to expressivity include: Marfan syndrome, Van der Woude Syndrome, and neurofibromatosis.

The characteristics of Marfan syndrome widely vary among individuals. The syndrome affects connective tissue in the body and has a spectrum of symptoms ranging from mild bone and joint involvement to severe newborn forms and cardiovascular disease. [15] This diversity in symptoms is a result of variable expressivity of the FBN1 gene found on chromosome 15 (see figure 2). [16] The gene product is involved in the proper assembly of microfibrils, which are structures found in connective tissues to provide support and elasticity. [16] In Marfan patients, different levels of FBN1 mRNA and FBN1 expression levels were observed. [17] These varying levels were not associated with either sex or age. Lower levels of mRNA expression were associated with a higher risk for ectopia lentis, the displacement of the crystalline lens of the eye, and pectus deformity, an abnormality of the chest muscle, indicating that variation in expression could be due to levels of expressivity and not genotype. [17]

Van der Woude syndrome is a condition that affects the development of the face, specifically a cleft lip, cleft palate or both (see Figure 3). [18] Carriers of the rare allele can also have pits near the centre of the lower lip which may appear to be wet due to the presence of salivary glands. [18] The resulting phenotypes expressed varies significantly among individuals. This variation can range so broadly that a study published by the Department of Orthodontics at the University of Athens showed that some individuals were unaware that they possessed the genotype for this condition until they were tested. [19]

Neurofibromatosis (NF1), also known as Von Recklinghausen disease, is a genetic disorder that is caused by a rare mutation in the neurofibromin gene (NF1) on chromosome 17. [20] This loss of function mutation in the tumor suppressor gene can cause tumors on the nerves called neurofibromas. [21] These appear as small bumps under the skin. It is stipulated that the phenotypic variation is a result of genetic modifiers. [21]

Some hemoglobinopathies (diseases of the blood) like Sickle Cell Anemia exist on a spectrum. Sickle Cell Anemia is an autosomal recessive, prototypical monogenic Mendelian disease, meaning that the disease follows Mendelian inheritance and is traced back to a single gene. Individuals with Sickle Cell Anemia present different severities of symptoms. Fetal Hemoglobin (HbF) concentration and the presence of alpha-thalassemia, a genetic blood disease in which the alpha globin subunit of the hemoglobin protein is underproduced, are thought to be major contributors to the genetic modification leading to the variable expressivity of hemolysis (destruction of red blood cells) and increasing the severity of the disease. [22]

See also

Related Research Articles

An allele, or allelomorph, is a variant of the sequence of nucleotides at a particular location, or locus, on a DNA molecule.

<span class="mw-page-title-main">Genetic disorder</span> Health problem caused by one or more abnormalities in the genome

A genetic disorder is a health problem caused by one or more abnormalities in the genome. It can be caused by a mutation in a single gene (monogenic) or multiple genes (polygenic) or by a chromosomal abnormality. Although polygenic disorders are the most common, the term is mostly used when discussing disorders with a single genetic cause, either in a gene or chromosome. The mutation responsible can occur spontaneously before embryonic development, or it can be inherited from two parents who are carriers of a faulty gene or from a parent with the disorder. When the genetic disorder is inherited from one or both parents, it is also classified as a hereditary disease. Some disorders are caused by a mutation on the X chromosome and have X-linked inheritance. Very few disorders are inherited on the Y chromosome or mitochondrial DNA.

The genotype of an organism is its complete set of genetic material. Genotype can also be used to refer to the alleles or variants an individual carries in a particular gene or genetic location. The number of alleles an individual can have in a specific gene depends on the number of copies of each chromosome found in that species, also referred to as ploidy. In diploid species like humans, two full sets of chromosomes are present, meaning each individual has two alleles for any given gene. If both alleles are the same, the genotype is referred to as homozygous. If the alleles are different, the genotype is referred to as heterozygous.

<span class="mw-page-title-main">Heredity</span> Passing of traits to offspring from the species parents or ancestor

Heredity, also called inheritance or biological inheritance, is the passing on of traits from parents to their offspring; either through asexual reproduction or sexual reproduction, the offspring cells or organisms acquire the genetic information of their parents. Through heredity, variations between individuals can accumulate and cause species to evolve by natural selection. The study of heredity in biology is genetics.

<span class="mw-page-title-main">Marfan syndrome</span> Genetic disorder involving connective tissue

Marfan syndrome (MFS) is a multi-systemic genetic disorder that affects the connective tissue. Those with the condition tend to be tall and thin, with long arms, legs, fingers, and toes. They also typically have exceptionally flexible joints and abnormally curved spines. The most serious complications involve the heart and aorta, with an increased risk of mitral valve prolapse and aortic aneurysm. The lungs, eyes, bones, and the covering of the spinal cord are also commonly affected. The severity of the symptoms is variable.

<span class="mw-page-title-main">Genotype–phenotype distinction</span> Distinction made in genetics

The genotype–phenotype distinction is drawn in genetics. The "Genotype" is an organism's full hereditary information. The "Phenotype" is an organism's actual observed properties, such as morphology, development, or behavior. This distinction is fundamental in the study of inheritance of traits and their evolution.

<span class="mw-page-title-main">Dominance (genetics)</span> One gene variant masking the effect of another in the other copy of the gene

In genetics, dominance is the phenomenon of one variant (allele) of a gene on a chromosome masking or overriding the effect of a different variant of the same gene on the other copy of the chromosome. The first variant is termed dominant and the second is called recessive. This state of having two different variants of the same gene on each chromosome is originally caused by a mutation in one of the genes, either new or inherited. The terms autosomal dominant or autosomal recessive are used to describe gene variants on non-sex chromosomes (autosomes) and their associated traits, while those on sex chromosomes (allosomes) are termed X-linked dominant, X-linked recessive or Y-linked; these have an inheritance and presentation pattern that depends on the sex of both the parent and the child. Since there is only one copy of the Y chromosome, Y-linked traits cannot be dominant or recessive. Additionally, there are other forms of dominance, such as incomplete dominance, in which a gene variant has a partial effect compared to when it is present on both chromosomes and co-dominance, in which different variants on each chromosome both show their associated traits.

Penetrance in genetics is the proportion of individuals carrying a particular variant of a gene that also expresses an associated trait. In medical genetics, the penetrance of a disease-causing mutation is the proportion of individuals with the mutation that exhibit clinical symptoms among all individuals with such mutation. For example, if a mutation in the gene responsible for a particular autosomal dominant disorder has 95% penetrance, then 95% of those with the mutation will develop the disease, while 5% will not.

A quantitative trait locus (QTL) is a locus that correlates with variation of a quantitative trait in the phenotype of a population of organisms. QTLs are mapped by identifying which molecular markers correlate with an observed trait. This is often an early step in identifying the actual genes that cause the trait variation.

<span class="mw-page-title-main">Noonan syndrome</span> Genetic condition involving facial, heart, blood and skeletal features

Noonan syndrome (NS) is a genetic disorder that may present with mildly unusual facial features, short height, congenital heart disease, bleeding problems, and skeletal malformations. Facial features include widely spaced eyes, light-colored eyes, low-set ears, a short neck, and a small lower jaw. Heart problems may include pulmonary valve stenosis. The breast bone may either protrude or be sunken, while the spine may be abnormally curved. Intelligence is often normal. Complications of NS can include leukemia.

<span class="mw-page-title-main">Human genetics</span> Study of inheritance as it occurs in human beings

Human genetics is the study of inheritance as it occurs in human beings. Human genetics encompasses a variety of overlapping fields including: classical genetics, cytogenetics, molecular genetics, biochemical genetics, genomics, population genetics, developmental genetics, clinical genetics, and genetic counseling.

<span class="mw-page-title-main">Haploinsufficiency</span> Concept in genetics

Haploinsufficiency in genetics describes a model of dominant gene action in diploid organisms, in which a single copy of the wild-type allele at a locus in heterozygous combination with a variant allele is insufficient to produce the wild-type phenotype. Haploinsufficiency may arise from a de novo or inherited loss-of-function mutation in the variant allele, such that it yields little or no gene product. Although the other, standard allele still produces the standard amount of product, the total product is insufficient to produce the standard phenotype. This heterozygous genotype may result in a non- or sub-standard, deleterious, and (or) disease phenotype. Haploinsufficiency is the standard explanation for dominant deleterious alleles.

Van der Woude syndrome (VDWS) is a genetic disorder characterized by the combination of lower lip pits, cleft lip with or without cleft palate (CL/P), and cleft palate only (CPO). The frequency of orofacial clefts ranges from 1:1000 to 1:500 births worldwide, and there are more than 400 syndromes that involve CL/P. VWS is distinct from other clefting syndromes due to the combination of cleft lip and palate (CLP) and CPO within the same family. Other features frequently associated with VWS include hypodontia in 10-81% of cases, narrow arched palate, congenital heart disease, heart murmur and cerebral abnormalities, syndactyly of the hands, polythelia, ankyloglossia, and adhesions between the upper and lower gum pads.

<span class="mw-page-title-main">Acrocephalosyndactyly</span> Group of diseases

Acrocephalosyndactyly is a group of congenital conditions characterized by irregular features of the face and skull (craniosynostosis) and hands and feet (syndactyly). Craniosynostosis occurs when the cranial sutures, the fibrous tissue connecting the skull bones, fuse the cranial bones early in development. Cranial sutures allow the skull bones to continue growing until they fuse at age 24. Premature fusing of the cranial sutures can result in alterations to the skull shape and interfere with brain growth. Syndactyly occurs when digits of the hands or feet are fused together. When polydactyly is also present, the classification is acrocephalopolysyndactyly. Polydactyly occurs when the hands or feet possess additional digits. Acrocephalosyndactyly is usually diagnosed after birth, although prenatal diagnosis is sometimes possible if the genetic variation is present in family members, as the conditions are typically inherited in an autosomal dominant pattern Treatment often involves surgery in early childhood to correct for craniosynostosis and syndactyly.

<span class="mw-page-title-main">Fibrillin-1</span> Protein-coding gene in the species Homo sapiens

Fibrillin-1 is a protein that in humans is encoded by the FBN1 gene, located on chromosome 15. It is a large, extracellular matrix glycoprotein that serves as a structural component of 10-12 nm calcium-binding microfibrils. These microfibrils provide force bearing structural support in elastic and nonelastic connective tissue throughout the body. Mutations altering the protein can result in a variety of phenotypic effects differing widely in their severity, including fetal death, developmental problems, Marfan syndrome or in some cases Weill-Marchesani syndrome.

<span class="mw-page-title-main">Polysyndactyly</span> Medical condition

Polysyndactyly is a congenital anomaly, combining polydactyly and syndactyly, in which affected individuals have an extra finger or toe that is connected, via fusing or webbing, to an adjacent digit.

Oligogenic inheritance describes a trait that is influenced by a few genes. Oligogenic inheritance represents an intermediate between monogenic inheritance in which a trait is determined by a single causative gene, and polygenic inheritance, in which a trait is influenced by many genes and often environmental factors.

<span class="mw-page-title-main">Genotype-first approach</span>

The genotype-first approach is a type of strategy used in genetic epidemiological studies to associate specific genotypes to apparent clinical phenotypes of a complex disease or trait. As opposed to “phenotype-first”, the traditional strategy that has been guiding genome-wide association studies (GWAS) so far, this approach characterizes individuals first by a statistically common genotype based on molecular tests prior to clinical phenotypic classification. This method of grouping leads to patient evaluations based on a shared genetic etiology for the observed phenotypes, regardless of their suspected diagnosis. Thus, this approach can prevent initial phenotypic bias and allow for identification of genes that pose a significant contribution to the disease etiology.

A human disease modifier gene is a modifier gene that alters expression of a human gene at another locus that in turn causes a genetic disease. Whereas medical genetics has tended to distinguish between monogenic traits, governed by simple, Mendelian inheritance, and quantitative traits, with cumulative, multifactorial causes, increasing evidence suggests that human diseases exist on a continuous spectrum between the two.

<span class="mw-page-title-main">Familial opposable triphalangeal thumbs duplication</span> Medical condition

Familial opposable triphalangeal thumb duplication is a limb malformation syndrome and a type of pre-axial polydactyly, characterized by having duplicated opposable triphalangeal thumbs. This condition can be a symptom of other genetic disorders, such as Holt–Oram syndrome and Fanconi anemia. This trait is autosomal dominant and often runs in families. Sometimes big toe duplication, post-axial polydactyly, and syndactyly of the hand and feet can occur alongside this malformation Approximately 20 families with the condition have been described in medical literature.

References

  1. Miko I (2008). "Phenotype variability: penetrance and expressivity". Nature Education. 1 (1): 137.
  2. Bourgeois, P (1998-06-01). "The variable expressivity and incomplete penetrance of the twist-null heterozygous mouse phenotype resemble those of human Saethre-Chotzen syndrome". Human Molecular Genetics. 7 (6): 945–957. doi: 10.1093/hmg/7.6.945 . ISSN   1460-2083.
  3. 1 2 Marian AJ, Roberts R (April 2001). "The molecular genetic basis for hypertrophic cardiomyopathy". Journal of Molecular and Cellular Cardiology. 33 (4): 655–70. doi:10.1006/jmcc.2001.1340. PMC   2901497 . PMID   11273720.
  4. Slavotinek A, Biesecker LG (April 2003). "Genetic modifiers in human development and malformation syndromes, including chaperone proteins". Human Molecular Genetics. 12 Spec No 1 (suppl_1): R45-50. doi: 10.1093/hmg/ddg099 . PMID   12668596.
  5. Peaston AE, Whitelaw E (May 2006). "Epigenetics and phenotypic variation in mammals". Mammalian Genome. 17 (5): 365–74. doi:10.1007/s00335-005-0180-2. PMC   3906716 . PMID   16688527.
  6. Wittkopp, Patricia J.; Kalay, Gizem (2011-12-06). "Cis-regulatory elements: molecular mechanisms and evolutionary processes underlying divergence". Nature Reviews Genetics. 13 (1): 59–69. doi:10.1038/nrg3095. ISSN   1471-0056.
  7. Metzger, Brian P. H.; Duveau, Fabien; Yuan, David C.; Tryban, Stephen; Yang, Bing; Wittkopp, Patricia J. (2016-01-18). "Contrasting Frequencies and Effects ofcis- andtrans-Regulatory Mutations Affecting Gene Expression". Molecular Biology and Evolution. 33 (5): 1131–1146. doi: 10.1093/molbev/msw011 . ISSN   0737-4038. PMC   4909133 .
  8. Peterson, Craig L; Laniel, Marc-André (2004). "Histones and histone modifications". Current Biology. 14 (14): R546–R551. doi: 10.1016/j.cub.2004.07.007 . ISSN   0960-9822.
  9. Martire, Sara; Banaszynski, Laura A. (2020-07-14). "The roles of histone variants in fine-tuning chromatin organization and function". Nature Reviews Molecular Cell Biology. 21 (9): 522–541. doi:10.1038/s41580-020-0262-8. ISSN   1471-0072. PMC   8245300 .
  10. Surani, Azim M. (1991). "Influence of genome imprinting on gene expression, phenotypic variations and development". Human Reproduction. 6 (1): 45–51. doi:10.1093/oxfordjournals.humrep.a137256. ISSN   1460-2350.
  11. Tukker, Anke M; Royal, Charmaine D; Bowman, Aaron B; McAllister, Kimberly A (2021-03-02). "The Impact of Environmental Factors on Monogenic Mendelian Diseases". Toxicological Sciences. 181 (1): 3–12. doi: 10.1093/toxsci/kfab022 . ISSN   1096-6080. PMC   8599782 .
  12. Sturtevant, A. H. (1913). "The Himalayan Rabbit Case, With Some Considerations on Multiple Allelomorphs". The American Naturalist. 47 (556): 234–239. doi:10.1086/279344. ISSN   0003-0147.
  13. 1 2 Immadi, Shobha; Patil, Shreekant; Maralappanavar, Manjula; Sajjanar, Gowramma (2014-01-10). "Penetrance, expressivity and inheritance of axillary branching in somaclonal mutant of sorghum (Sorghum bicolor L.)". Euphytica. 196 (3): 449–457. doi:10.1007/s10681-013-1046-4. ISSN   0014-2336.
  14. Hamelin, Alexia; Conchou, Fabrice; Fusellier, Marion; Duchenij, Bettina; Vieira, Isabelle; Filhol, Emilie; Dufaure de Citres, Caroline; Tiret, Laurent; Gache, Vincent; Abitbol, Marie (2020-02-18). "Genetic heterogeneity of polydactyly in Maine Coon cats". Journal of Feline Medicine and Surgery. 22 (12): 1103–1113. doi:10.1177/1098612x20905061. ISSN   1098-612X.
  15. "Marfan syndrome". Genetics Home Reference. Retrieved 2019-10-09.
  16. 1 2 "FBN1 gene". Genetics Home Reference. Retrieved 2019-10-09.
  17. 1 2 Aubart, Mélodie; Gross, Marie-Sylvie; Hanna, Nadine; Zabot, Marie-Thérèse; Sznajder, Marc; Detaint, Delphine; Gouya, Laurent; Jondeau, Guillaume; Boileau, Catherine; Stheneur, Chantal (2015-02-04). "The clinical presentation of Marfan syndrome is modulated by expression of wild-type FBN1 allele". Human Molecular Genetics. 24 (10): 2764–2770. doi: 10.1093/hmg/ddv037 . ISSN   1460-2083.
  18. 1 2 "Van der Woude syndrome". Genetics Home Reference. Retrieved 2019-10-09.
  19. Rizos M, Spyropoulos MN (February 2004). "Van der Woude syndrome: a review. Cardinal signs, epidemiology, associated features, differential diagnosis, expressivity, genetic counselling and treatment". European Journal of Orthodontics. 26 (1): 17–24. doi: 10.1093/ejo/26.1.17 . PMID   14994878.
  20. "Neurofibromatosis". medlineplus.gov. Retrieved 2019-10-09.
  21. 1 2 Sabbagh A, Pasmant E, Laurendeau I, Parfait B, Barbarot S, Guillot B, et al. (August 2009). "Unravelling the genetic basis of variable clinical expression in neurofibromatosis 1". Human Molecular Genetics. 18 (15): 2768–78. doi:10.1093/hmg/ddp212. PMC   2722187 . PMID   19417008.
  22. Habara, Alawi; Steinberg, Martin H (2016-03-01). "Minireview: Genetic basis of heterogeneity and severity in sickle cell disease". Experimental Biology and Medicine. 241 (7): 689–696. doi:10.1177/1535370216636726. ISSN   1535-3702. PMC   4950383 .

Further reading